Search Details

Word: hodgkin (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...profitability at the proposed Biogen IDEC, where he would be CEO, is already part of the culture at top industry players Amgen and Genentech. So he's got a blueprint--and a lot to work with. Biogen's Avonex for multiple sclerosis and IDEC's Rituxan for non-Hodgkin's lymphoma each generate more than $1 billion in annual sales, and both companies are solidly profitable. Yet "the combination will create more value than either could as separate entities," says William Rastetter, CEO of IDEC, who would get the title of executive chairman after the merger. The focus on managing...

Author: /time Magazine | Title: Will This Experiment Work? | 7/7/2003 | See Source »

...slowing the biopharmers. Open-air trials of pharmaceutical crops have taken place in 14 states, from Hawaii to Maryland. A Texas firm is selling a corn-bred enzyme that stimulates insulin production in diabetics. Clinical trials have begun for experimental crop-grown drugs to treat cystic fibrosis, non-Hodgkin's lymphoma and hepatitis B. "Molecular farming represents the pharmaceutical industry's best opportunity to strike a serious blow against such global diseases as AIDS, Alzheimer's and cancer," says Francois Arcand, president of the Conference on Plant-Made Pharmaceuticals, held in Quebec City earlier this year...

Author: /time Magazine | Title: Cures On the Cob | 5/26/2003 | See Source »

DIED. RICHARD HARRIS, 72, hell-raising Irish actor; of Hodgkin's disease; in London. He first won acclaim for his starring role as a rugby player in This Sporting Life (1963) and later starred in such films as Camelot and A Man Called Horse. A new generation knew him as the kindly wizard Dumbledore in Harry Potter and the Sorcerer's Stone, a role he reprises in next month's sequel...

Author: /time Magazine | Title: Milestones Nov. 4, 2002 | 11/4/2002 | See Source »

...case of the Jacobses, that could be a lifesaver. Derek has allergies to common antibiotics, and Jeffrey is weakened from years of treatment for Hodgkin's disease. A few years ago, he was in a serious car accident; and when he got to the hospital, he was in no shape to explain his condition to the staff. "The advantage of the chip is that the information is available at the time of need," Jeffrey explains. "It would speak for me, give me a voice when I don't have...

Author: /time Magazine | Title: Meet The Chipsons | 3/11/2002 | See Source »

...learned over the years that cancer cells are studded with an unusually large number of receptacles that compounds essential for survival, including growth factors, can plug into and fuel the cells' growth. Rituxan is a monoclonal antibody, a molecule specifically engineered to fit into the receptacles on non-Hodgkin's lymphoma cells and, in this case, single out the cancer cell for destruction by the immune system. Back in the early 1980s, monoclonal antibodies were hyped in the media as "magic bullets" that would wipe out cancer...

Author: /time Magazine | Title: New Hope For Cancer | 5/28/2001 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next